The vaccine obtains Brazilian regulatory approval and complete Phase 3 clinical trials, or large-scale human trials, before being produced in Brazil, southern state officials said.
Production, if continued, would not begin until 2021, said Jorge Callado, holder of the Paraná Institute of Technology, who signed the agreement with the Russian Direct Investment Fund (RDIF).
“This is a very objective Memorandum of Understanding on generational exchange. It imposes obligations, it only allows us to paint together,” he said at a virtual press conference.
He said the agreement, Russia would percentize the effects of Phases 1 and 2 of the trials with the state.
President Vladimir Putin announced Tuesday that Russia had approved the vaccine, dubbed “Sputnik V,” in a world premiere, and said it would turn the game into a pandemic.
But foreign fitness officials have warned that more evidence and controls are needed to make sure it is effective.
Brazil has a popular testing floor for COVID-19 vaccines, as the new coronavirus is still spreading rapidly.
The country has the current number of infections and deaths in the pandemic, after the United States: more than 3.1 million and 104,000, respectively.